Tuesday, July 09, 2024 8:45:16 AM
Gets Past $2.00+ then $10.00+ in the play Charts says it all.
Killing all kinds of cancers with follow up Data on patients for 5 years and counting.
This stock should be trading 10-30x the current market cap more inline with Pulse Bio Sciences a Billion dollar market cap that has no revenue and is doing just cosmetic dermatology skin treatments.That stock was trading around a dollar a few years ago.
IceCure will make some people hyper wealthy.
$ICCM
Killing all kinds of cancers with follow up Data on patients for 5 years and counting.
This stock should be trading 10-30x the current market cap more inline with Pulse Bio Sciences a Billion dollar market cap that has no revenue and is doing just cosmetic dermatology skin treatments.That stock was trading around a dollar a few years ago.
IceCure will make some people hyper wealthy.
$ICCM
Bullish
Recent ICCM News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/21/2026 12:45:12 PM
- IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 • PR Newswire (US) • 04/21/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:25 AM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 04/01/2026 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 12:49:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:11:32 AM
- IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement • PR Newswire (US) • 03/26/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 12:45:01 PM
- IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates • PR Newswire (US) • 03/25/2026 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 12:45:08 PM
- IceCure Appoints Meir Peleg as Chief Financial Officer • PR Newswire (US) • 03/24/2026 12:30:00 PM
- Form F-3/A - Registration statement by foreign private issuers: [Amend] • Edgar (US Regulatory) • 03/20/2026 08:02:02 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/20/2026 08:01:22 PM
